Furthermore, activation of the NF-kB pathway via the KYNA–HCAR3 axis may promote the transcription of genes involved in cell survival, angiogenesis, invasiveness, and immune response modulation, collectively contributing to cancer progression [14,38,51,52,59]. The gene discussed is NFKB1; the disease is cancer.